← All trials
NCT03291418
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 8, 2017
- Primary completion
- Mar 31, 2018
- Completion date
- Apr 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 258
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Antibe TherapeuticsLead sponsor
- Topstone Research, Toronto, CanadaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.